8 results
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
anticoagulation #clotting ... #INR #heparin #LMWH ... #NOAC #warfarin ... apixaban #Eliquis #dabigatran
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Kcentra) - Heparin/LMWH ... Protamine sulfate - Dabigatran ... anticoagulation #doac ... #noac #pharmacology
Effect of Anticoagulants on Coagulation Tests
PT / INR, aPTT, Anti-Xa Activity, Activated Clotting Time, Thrombin Time,
Activity, Activated Clotting ... Thrombin Time, Ecarin Clotting ... Warfarin UFH LMWH ... Argatroban Dabigatran
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Weight Heparin (LMWH ... ) inhibitors - Dabigatran ... #medications #doac
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
(e.g. heparin, LMWH ... weight heparin (LMWH ... Pathophysiology #Heparins #LMWH ... #UFH #DOAC #Dabigatran ... #Fondaparinux #NOAC
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
initiated after a LMWH ... ¥LMWH is currently ... DOAC, direct oral ... anticoagulant; LMWH ... #DOAC #VTE #Malignancy
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... filtration rate; DOAC ... anticoagulant; LMWH ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm
Effect of Direct Oral Anticoagulants on Hemostatic Tests
Horizontal bars correspond to the approximate range of detectability
concentrations of dabigatran ... ; ECT = ecarin clotting ... thrombin time #doac ... #noac #anticoagulation